Literature DB >> 14607619

Unique pattern of fibrosing cholestatic hepatitis after liver transplantation.

Jia-Wei Chen1, Da-Zhi Chen, Zhao-Min Chen.   

Abstract

OBJECTIVE: To explore the pathological features and the differential diagnosis of recurrent HBV after liver transplantation.
METHODS: One case of liver transplantation for HBV cirrhosis was subjected to liver biopsies on time postoperatively.
RESULTS: 25 days after liver transplantation, serologic HBsAg, HBeAg and HBV-DNA of the patient became negative, but HBsAg was positive again on day 58 after liver transplantation. Histopathological examination showed balloon-like changes of hepatocytes with fragmental necrosis, fibrosis in the portal areas and around the portal veins, cholestasis in some hepatocytes and canaliculi, and positive HBsAg and HBcAg with immunohistochemical staining. clinically hepatic enzyme levels progressively increased, maintained for some time, and decreased rapidly at last. Stubborn hypoproteinemia was associated with the aggregation of general condition of the patient.
CONCLUSIONS: Fibrosing cholestatic hepatitis (FCH) is a special type in recurrent infection of HBV after liver transplantation. It has a serious clinical process and specific pathological changes different from those of the usual HBV.

Entities:  

Mesh:

Year:  2002        PMID: 14607619

Source DB:  PubMed          Journal:  Hepatobiliary Pancreat Dis Int


  2 in total

1.  Clinicopathological conference: fibrosing cholestatic hepatitis presenting as subacute hepatic failure in a non-transplant patient.

Authors:  Ajay Duseja; Ashim Das; Y K Chawla; Anil Bhansali; V Sakhuja
Journal:  Dig Dis Sci       Date:  2009-07-23       Impact factor: 3.199

2.  A YIDD Mutation in a Case of Recurrent Hepatitis B after Liver Transplantation Induced by an S-escape Mutant.

Authors:  Yun-Jung Oh; Young-Min Park; Sun-Pyo Hong; Soo-Kyeong Shin; Seung-Il Ji; Bo-Hyun Kim; Sang-Jong Park; Zheng Hong
Journal:  Gut Liver       Date:  2010-06-16       Impact factor: 4.519

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.